-
Ligand Pharmaceuticals (NASDAQ:LGND) Issues FY 2025 Earnings Guidance
Source: Buzz FX / 28 Feb 2025 07:01:15 America/Chicago
Ligand Pharmaceuticals (NASDAQ:LGND) Issues FY 2025 Earnings Guidance Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Ligand Pharmaceuticals ( NASDAQ:LGND - Get Free Report ) updated its FY 2025 earnings guidance on
Read more...